BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cho H. Renal replacement therapy in neonates with an inborn error of metabolism. Korean J Pediatr 2019;62:43-7. [PMID: 30404428 DOI: 10.3345/kjp.2018.07143] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Ames EG, Luckritz KE, Ahmad A. A retrospective review of outcomes in the treatment of hyperammonemia with renal replacement therapy due to inborn errors of metabolism. Pediatr Nephrol 2020;35:1761-9. [DOI: 10.1007/s00467-020-04533-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Eminoğlu FT, Öncül Ü, Kahveci F, Okulu E, Kraja E, Köse E, Kendirli T. Characteristics of continuous venovenous hemodiafiltration in the acute treatment of inherited metabolic disorders. Pediatr Nephrol 2021. [PMID: 34693482 DOI: 10.1007/s00467-021-05329-9] [Reference Citation Analysis]
3 Ganesh R, Rajendran S, Arunkumar S, Karthik Narayanan R, Yadav R. Continuous Venovenous Hemodiafilteration for Extremely High Ammonia Levels in Methyl Malonic Acidemia. Indian J Pediatr 2021;88:272-3. [PMID: 32468386 DOI: 10.1007/s12098-020-03344-6] [Reference Citation Analysis]
4 Abily-Donval L, Dupic L, Joffre C, Brassier A, Arnoux JB, Grimaud M, Lesage F, de Saint Blanquat L, Bekri S, Marret S, Pontoizeau C, Renolleau S, Ottolenghi C, de Lonlay P, Oualha M. Management of 35 critically ill hyperammonemic neonates: Role of early administration of metabolite scavengers and continuous hemodialysis. Arch Pediatr 2020;27:250-6. [PMID: 32418642 DOI: 10.1016/j.arcped.2020.05.002] [Reference Citation Analysis]
5 Raina R, McCulloch M, Nourse P, Sethi SK, Yap HK. Advances in Kidney Replacement Therapy in Infants. Adv Chronic Kidney Dis 2021;28:91-104. [PMID: 34389141 DOI: 10.1053/j.ackd.2021.05.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
6 Ravindranath A, Sarma MS. Mitochondrial hepatopathy: Anticipated difficulties in management of fatty acid oxidation defects and urea cycle defects. World J Hepatol 2022; 14(1): 180-194 [DOI: 10.4254/wjh.v14.i1.180] [Reference Citation Analysis]